The utilisation of syringe exchange services by anabolic steroid (AS) injectors has increased over the last fifteen years to such an extent that in some areas new AS injecting clients now outnumber all other injectors combined. This course will explore the reasons for this phenomenon, the implications for service delivery and how practitioners may face the challenge of providing harm reduction interventions to this service user group.